Merchants Quay Ireland welcomes development of negotiations for wider availability of suboxone

Merchants Quay Ireland welcomes development of negotiations for wider availability of suboxone

Merchants Quay Ireland, the national homeless and drugs charity, has welcomed news reported by the Medical Independent on negotiations for wider availability of suboxone being at advanced stages.

Suboxone is the brand name of buprenorphine, and is an opioid used to treat opioid addiction. By allowing wider availability of suboxone, it provides increased options for people caught in addiction.

Speaking on the news, CEO of Merchants Quay Ireland Tony Geoghegan said:

“MQI has long advocated for increased treatment options for people who use drugs and welcomes the news that increased availability of buprenorphine is finally being progressed.

“With almost 10,000 people on methadone treatment in Ireland it is imperative that we begin to offer people in addiction more treatment options.

“The wider availability of suboxone will finally see Ireland move away from the usual ‘one size fits all’ approach to treatment. I hope that all parties involved in the negotiations can seize this opportunity to make a real different in the lives of people who use drugs.”

 

-ENDS-

For more information or to arrange an interview with our spokesperson, Tony Geoghegan, please contact:

Andrew Rooney

086 7793 208 or e-mail andrew.rooney@mqi.ie